1. Home
  2. BNTC vs NPCE Comparison

BNTC vs NPCE Comparison

Compare BNTC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • NPCE
  • Stock Information
  • Founded
  • BNTC 1995
  • NPCE 1997
  • Country
  • BNTC United States
  • NPCE United States
  • Employees
  • BNTC N/A
  • NPCE N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • NPCE Medical Specialities
  • Sector
  • BNTC Health Care
  • NPCE Health Care
  • Exchange
  • BNTC Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • BNTC 365.1M
  • NPCE 328.8M
  • IPO Year
  • BNTC N/A
  • NPCE 2021
  • Fundamental
  • Price
  • BNTC $13.06
  • NPCE $14.13
  • Analyst Decision
  • BNTC Strong Buy
  • NPCE Strong Buy
  • Analyst Count
  • BNTC 5
  • NPCE 7
  • Target Price
  • BNTC $26.60
  • NPCE $17.00
  • AVG Volume (30 Days)
  • BNTC 304.0K
  • NPCE 232.0K
  • Earning Date
  • BNTC 11-14-2025
  • NPCE 11-04-2025
  • Dividend Yield
  • BNTC N/A
  • NPCE N/A
  • EPS Growth
  • BNTC N/A
  • NPCE N/A
  • EPS
  • BNTC N/A
  • NPCE N/A
  • Revenue
  • BNTC N/A
  • NPCE $94,864,000.00
  • Revenue This Year
  • BNTC N/A
  • NPCE $22.13
  • Revenue Next Year
  • BNTC N/A
  • NPCE $6.07
  • P/E Ratio
  • BNTC N/A
  • NPCE N/A
  • Revenue Growth
  • BNTC N/A
  • NPCE 24.08
  • 52 Week Low
  • BNTC $9.10
  • NPCE $7.56
  • 52 Week High
  • BNTC $17.15
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 39.49
  • NPCE 72.46
  • Support Level
  • BNTC $12.47
  • NPCE $12.63
  • Resistance Level
  • BNTC $13.94
  • NPCE $13.65
  • Average True Range (ATR)
  • BNTC 1.27
  • NPCE 0.81
  • MACD
  • BNTC -0.18
  • NPCE 0.17
  • Stochastic Oscillator
  • BNTC 29.06
  • NPCE 97.42

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: